期刊文献+

复方盐酸奈福泮萘普生钠缓释胶囊的制备和工艺考察 被引量:1

Preparation and Technology Investigation of Compound Nefopam Hydrochloride and Naproxen Sodium Sustained-Release Capsule
原文传递
导出
摘要 目的应用挤出滚圆法及流化床包衣制备盐酸奈福泮缓释微丸和萘普生钠肠溶缓释微丸,并对各自性质进行考察。方法采用国产挤出滚圆机制备盐酸奈福泮微丸和萘普生钠微丸,运用L9(34)正交设计实验优化工艺条件;用微型流化床包衣设备,将盐酸奈福泮微丸包缓释衣、萘普生钠微丸包肠溶衣和缓释衣,分别考察两种微丸的粉体学性质及不同包衣增重微丸的体外释放实验。结果制得的盐酸奈福泮缓释微丸和萘普生钠肠溶缓释微丸圆整度好,大小均匀,体外释放也比较理想。结论应用挤出滚圆机制备盐酸奈福泮微丸和萘普生钠微丸工艺简便,圆整度好,硬度适宜,收率较高;采用适当的包衣工艺,可制得质量良好的盐酸奈福泮缓释微丸和萘普生钠肠溶缓释微丸。 OBJECTIVE To prepare nefopam hydrochloride(Nef) pellets and naproxen sodium (Npx-S) enteric-coated sustainedrelease pellets by the extrusion spheronization technology and the fluidized bed coating technology and to determine the pellets' properties. METHODS Nef pellets and Npx-S pellets were prepared using extrusion spheronization equipment. L9 (34 ) orthogonal design was used to obtain optimal formulation. Using fluid bed coating equipment, the Nef pellets were coated with sustained-release coats, the Npx-S pellets were coated with enteric coats and sustained-release coats. The micromeritic properties and in vitro dissolution of the two preparations were determined. RESULTS The pellets were round, smooth and even. The in vitro dissolution was also perfect. CONCLUSION The process of extrusion spheronization for preparing pellets is simpte and quick with excellent quality of pellets. Appling a proper coating technology, the coated pellets can be made successfully.
出处 《中国药学杂志》 CAS CSCD 北大核心 2011年第8期605-609,共5页 Chinese Pharmaceutical Journal
关键词 盐酸奈福泮 萘普生钠 挤出滚圆 微丸 流化床包衣 体外释放度 nefopam hydrochloride naproxen sodium extrusion spheronization pellets fluidized bed coating technology dissolution in vitro
  • 相关文献

参考文献2

二级参考文献13

  • 1董志超,蒋雪涛.羟丙基甲基纤维素在凝胶骨架中的含量与水溶性药物释放机制的关系[J].药学学报,1996,31(1):43-47. 被引量:31
  • 2平其能 郑梁元.药用聚合物的理论和实践[M].北京:中国医药科技出版社,1994.410-412.
  • 3Davies DE,Dewland PM,Donnell D,et al.A study of nefopam kinetics after single and multiple oral doses in young and elderly volunteers[J].Br J Pharmacol,1986;S,143.
  • 4Burton LC,Loftus NJ,Vere DW,et al.Determination of plasma nefopam by liquid chromatography and electrochemical detection [J].J Chromatogr,1990;526(1):159-168.
  • 5Chawla J,Le Guern ME,Alquier C,et al.Effect of route of administration on the pharmacokinetic behavior of enantiomers of nefopam and desmethylnefopam[J].Ther Drug Monit,2003;25(2):203-210.
  • 6Guy Aymard,Dominique Warot,Pierre De′molis,et al.Comparative pharmacokinetics and pharmacodynamics of intravenous and oral Nefopam in healthy volunteers[J].Pharmacol Toxicol,2003;92(6):279-286.
  • 7Aymard G,Warot D,Demolis P,et al.Sensitive determination of nefopam and its metabolite desmethyl nefopam in human biological fluids by HPLC[J].J Pharm Biomed Anal,2002;30(4):1013-1021.
  • 8丁兰,郭利民,邹美南.奈福泮的少见不良反应[J].医药导报,1998,17(2):122-122. 被引量:1
  • 9赵京霞,王为忠,宋维亮,吴国生,罗宁宁,陈新莉,徐菊丽.小肠移植术后肠内营养因素对FK506血药浓度的影响[J].第四军医大学学报,2000,21(6):779-780. 被引量:17
  • 10谢林,张晓楠,严铭娟,张琳,刘晓东.HPLC法测定生物样品中盐酸奈福泮的含量[J].中国药科大学学报,2000,31(5):365-367. 被引量:10

共引文献5

同被引文献20

  • 1冯年平,屠锡德.盐酸拉贝洛尔缓释片及其药动学研究[J].中国药科大学学报,1996,27(1):13-15. 被引量:5
  • 2Dashevsky A, Mohamad A. Development of pulsatile muhiplarticulate drug delivery system coated with aqueous dispersion Aquacoat (R) ECD [J]. International journal of pharmaceutics, 2006,318 (1-2) : 124-131.
  • 3Jagdale SC, Chede SM, Gulwady R,et al. Pulsatile Multiparticulate Drug Delivery System for Metoprolol Succinate. Archives of Pharmacal Research [J]. 2011,34(3):369-376.
  • 4Hung SF, Hsieh CM, Chen YC, et al. Formulation and process optimization of muhiparticulate pulsatile system delivered by osmotic pressure-activated rupturable membrane [J]. International journal of pharmaceutics, 2015,480(1-2) : 15-26.
  • 5Chaudhary SS,Patel HK,Parejiya PB,et aL Chronomodulated drug delivery system of urapidil for the treatment of hypertension[J]. Int J Pharm Investig,2015,5 (2) : 107- 113.
  • 6Yadav D, Survase S,Kumar N. Dual coating of swellable and rupturable polymers on Glipizide loaded MCC pellets for pulsatile delivery: Formulation design and in vitro evaluation [J]. International Journal of Pharmaceutics, 2011,419(1-2) : 121-130.
  • 7Sungthongjeen S,Puttipipatkhachorn S,Paeratakul O,et al. Development of pulsatile release tablets with swelling and rupturable layers [J]. Journal of controlled release, 2004,95(2) : 147-159.
  • 8Bussemer T, Bodmeier R. Formulation parameters affecting the performance of coated gelatin capsules with pulsatile release profiles [J]. International Journal of Pharmaceutics, 2003,267(1-2) : 59-68.
  • 9刘耀,刘松青.挤出-滚圆法制备微丸的研究进展[J].中国药学杂志,2008,43(6):401-405. 被引量:23
  • 10常乃丹,于辉,彭海生,张宁.葛根素微丸制备及含量测定方法[J].中国医药导报,2011,8(30):60-62. 被引量:5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部